Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Updates on mechanisms of disease progression in precursor myeloma: Monoclonal gammopathy of undermined significance and smoldering myeloma

La Presse Médicale(2025)10.1016/j.lpm.2025.104268Source: DataRank Database

Updates on mechanisms of disease progression in precursor myeloma: Monoclonal gammopathy of undermined significance and smoldering myeloma is a research paper published in La Presse Médicale (2025). On theSindex it has a DataRank of 0. It has been cited 12 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

12 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (1 grants)Impact (FWCI 8.53)OA: closedTopics (29)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Irene M. Ghobrial ORCID,Cynthia Saade

Live enrichment

PubMed:39832697 OpenAlex:https://openalex.org/W4406559600

NIH

FWCI

8.53

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S0755498225000016?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0755498225000016?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.lpm.2025.104268

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39832697

Fields of Study

Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsCancer therapeutics and mechanismsMedicineHumansDisease ProgressionSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaPrognosis

MeSH Terms

Smoldering Multiple MyelomaHumansMonoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaPrecancerous ConditionsPrognosisDisease Progression

Keywords

Multiple myelomaMonoclonal gammopathy of undetermined significanceMonoclonal gammopathyPlasmacytomaMedicineMonoclonalMonoclonal antibodyImmunologyAntibodyRisk stratificationDisease ProgressionSmoldering Multiple Myeloma

Sustainable Development Goals

SDG 0: Zero hunger